CLOVHealthcareSmall-Cap
CLOVER HEALTH INVESTMENTS, CORP. /DE Insider Trading Activity
Every SEC Form 4 insider transaction reported for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CLOV insiders buying or selling?
CLOVER HEALTH INVESTMENTS, CORP. /DE insiders reported 10 open-market buys ($13.7M) and 34 sells ($6.4M) across 44 Form 4 filings — a net buying position of $7.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 20, 2026)
Total Form 4 filings
44
SEC EDGAR
Insider filers
13
Insider buys (10)
$13.7M
Insider sells (34)
$6.4M
Insider sentiment
Net buyingNet insider flow of $7.3M in net buying.
Recent CLOV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Karen Soares | Chief Legal Officer | Sale | 51.7K | $4.51 | $233.2K |
| Jul 17, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 4.8K | $4.53 | $21.9K |
| Jul 16, 2026 | Andrew Toy | Chief Executive Officer | Sale | 62.7K | $4.67 | $292.9K |
| Jul 16, 2026 | Conrad Wai | CEO, Counterpart Health | Sale | 24.2K | $4.67 | $113.1K |
| Jul 16, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 13.1K | $4.67 | $61.3K |
| Jul 16, 2026 | Karen Soares | Chief Legal Officer | Sale | 10.5K | $4.67 | $49.1K |
| Jul 16, 2026 | Joseph Clay Thornton | Interim CFO | Sale | 4.6K | $4.67 | $21.6K |
| Jul 9, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 2.4K | $4.68 | $11.2K |
| Jul 6, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 6.2K | $5.26 | $32.8K |
| Jul 1, 2026 | Andrew Toy | Chief Executive Officer | Sale | 313.5K | $5.32 | $1.7M |
| Jun 18, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 2.4K | $4.78 | $11.3K |
| Jun 17, 2026 | Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | Sale | 12.1K | $4.86 | $58.8K |
| Jun 16, 2026 | Karen Soares | Chief Legal Officer | Sale | 4.7K | $4.61 | $21.6K |
| Jun 16, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 6.3K | $4.61 | $29.3K |
| Jun 11, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 7.3K | $4.91 | $35.8K |
| May 28, 2026 | Conrad Wai | CEO, Counterpart Health | Sale | 220.4K | $3.99 | $879.5K |
| May 19, 2026 | Carladenise Armbrister Edwards | Director | Sale | 67.2K | $3.42 | $229.7K |
| May 14, 2026 | Brady Patrick Priest | CEO of Clover Care Services | Sale | 98.0K | $3.52 | $345.1K |
| Mar 18, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 5.8K | $1.91 | $11.1K |
| Jan 20, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 4.6K | $2.58 | $11.9K |
| Jan 7, 2026 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 2.1K | $2.53 | $5.3K |
| Dec 19, 2025 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 4.9K | $2.61 | $12.8K |
| Nov 5, 2025 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 30.4K | $3.58 | $108.8K |
| Oct 21, 2025 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 16.5K | $2.69 | $44.4K |
| Oct 7, 2025 | Jamie L. Reynoso | CEO, Medicare Advantage | Sale | 2.0K | $2.65 | $5.3K |
Showing the 25 most recent of 44 Form 4 filings for CLOVER HEALTH INVESTMENTS, CORP. /DE.
Most active CLOV insiders
- Jamie L. Reynoso18 filings
- Anna U Loengard4 filings
- Conrad Wai4 filings
- Karen Soares4 filings
- Garipalli Vivek3 filings
Ask anything about CLOV insider activity
Use Trabud's AI agent to query CLOVER HEALTH INVESTMENTS, CORP. /DE's Form 4 history in plain English — "Show me CLOV CEO purchases this year" or compare it against any other ticker.
Open the AI agentCLOV insider trading FAQ
Are CLOVER HEALTH INVESTMENTS, CORP. /DE insiders buying or selling?
Across 44 SEC Form 4 filings, CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) insiders reported 10 open-market purchases totaling $13.7M and 34 sales totaling $6.4M. That is a net buying position of $7.3M.
How many insiders trade CLOV stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CLOVER HEALTH INVESTMENTS, CORP. /DE. The most recent filing was accepted on Jul 20, 2026.
Where does Trabud get CLOV insider trading data?
All CLOV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.